What is the management approach for a patient diagnosed with Stevens-Johnson (Toxic Epidermal Necrolysis) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis

The management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) requires immediate transfer to a burn center or intensive care unit with experience in treating these conditions, along with prompt withdrawal of any suspected causative drug.1

Initial Assessment and Triage

  1. Immediate actions:

    • Discontinue all potential culprit drugs immediately
    • Calculate SCORTEN within first 24 hours to assess mortality risk
    • Transfer patients with >10% body surface area (BSA) epidermal loss to a burn center or ICU
  2. Essential investigations:

    • Full blood count, electrolytes, liver function tests, glucose, magnesium, phosphate
    • Chest X-ray
    • Skin biopsy (from lesional skin adjacent to a blister)
    • Swabs from lesional skin for bacterial culture

Supportive Care

Environment and Nursing

  • Barrier-nurse in a side room with controlled humidity
  • Use pressure-relieving mattress
  • Maintain ambient temperature between 25°C and 28°C 1
  • Establish peripheral venous access through non-lesional skin

Skin Management

  • Conservative approach:

    • Gently cleanse wounds with warmed sterile water, saline or dilute chlorhexidine
    • Apply greasy emollient (50% white soft paraffin with 50% liquid paraffin) over entire epidermis
    • Leave detached epidermis in situ as a biological dressing
    • Decompress blisters by piercing and draining fluid
    • Apply non-adherent dressings (e.g., Mepitel) to denuded areas
    • Use secondary foam or burn dressings to collect exudate 1
  • Monitoring for infection:

    • Take swabs from three areas of lesional skin on alternate days
    • Only administer systemic antibiotics if clinical signs of infection present 1

Mucosal Care

  1. Ocular management:

    • Daily ophthalmological review during acute illness
    • Apply preservative-free lubricants every 2 hours
    • Use topical antibiotics if corneal fluorescein staining or ulceration present
    • Prevent corneal exposure in unconscious patients 1
  2. Oral care:

    • Daily oral review during acute illness
    • Apply white soft paraffin to lips every 2 hours
    • Clean mouth daily with warm saline mouthwashes
    • Use benzydamine hydrochloride rinse every 3 hours
    • Apply chlorhexidine oral rinse twice daily
    • Use betamethasone sodium phosphate mouthwash four times daily 1
  3. Urogenital care:

    • Daily urogenital review during acute illness
    • Apply white soft paraffin to urogenital skin/mucosae every 4 hours
    • Use potent topical corticosteroid ointment on non-eroded surfaces
    • Apply silicone dressings to eroded areas
    • Insert urinary catheter if significant dysuria/retention 1

Respiratory Management

  • Monitor for respiratory symptoms and hypoxemia
  • If present, arrange urgent discussion with intensivist and transfer to ICU
  • Perform fibreoptic bronchoscopy in ICU/burn center setting 1

Systemic Therapy

While the U.K. guidelines do not strongly recommend specific systemic therapies, recent research suggests potential benefits:

  • Cyclosporine A has shown increasing evidence of decreasing mortality 2
  • Systemic corticosteroids remain one of the most common treatments, though efficacy is uncertain 2
  • Combination therapy with corticosteroids and IVIG may warrant further study, as it showed the lowest standardized mortality ratio (0.52) in a large U.S. cohort 3

Discharge and Follow-up

  • Provide written information about drugs to avoid
  • Encourage wearing a MedicAlert bracelet
  • Document drug allergy clearly in patient records
  • Report the episode to pharmacovigilance authorities
  • Arrange dermatology and ophthalmology follow-up within weeks of discharge 1

Common Pitfalls to Avoid

  1. Delayed recognition and transfer - Early recognition and prompt transfer to specialized units is crucial for survival 4

  2. Continuing the culprit drug - Immediate withdrawal of suspected causative agents is mandatory 5

  3. Inadequate mucosal care - Neglecting daily monitoring of mucosal surfaces can lead to long-term complications including strictures and adhesions 6

  4. Inappropriate antibiotic use - Only administer systemic antibiotics when there are clinical signs of infection, not prophylactically 1

  5. Overlooking long-term sequelae - Arrange appropriate follow-up with dermatology, ophthalmology, and other specialists to manage potential complications 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.